CARLSBAD, Calif., April 20 /PRNewswire/ -- RoboDesign International, Inc., announced today that the Novartis Institutes for BioMedical Research (NIBR) in Basel, Switzerland (Novartis AG), has selected CrystalMation(TM) as a platform for its protein crystal imaging and analysis. CrystalMation, a fully modular and automated protein crystallization system, includes equipment for liquid handling, low volume dispense, imaging, storage and analysis.
(Logo: http://www.newscom.com/cgi-bin/prnh/20030603/ROBODESIGNLOGO )
NIBR will be integrating RoboDesign's Minstrel III(TM) and RoboIncubator(TM) combinations, the core of the CrystalMation technology, at their Basel site beginning in June 2004. The Minstrel III, an ultra-high resolution imaging system, can quickly and consistently image hanging, sitting, or microbatch drops in any plate type. As with all of the CrystalMation components, the Minstrel III was designed to be expandable and modular, and can be expanded with a wide array of software tools and multiple RoboIncubators, a temperature controlled plate storage and retrieval system.
Robert L. Corey, president and CEO of RoboDesign stated, "NIBR needs a protein crystal imaging and analysis system that could meet their demanding requirements for performance and reliability. As with our continuing relationships with many of the world's leading pharmaceutical, biotech, and research organizations, NIBR's decision to implement our technology further validates CrystalMation as a leading protein crystallization platform. We are pleased and excited to be working with the research division of Novartis, a world leader in helping to improve patients lives and look forward to a long and successful relationship."
About RoboDesign(R) International Inc.
RoboDesign International, Inc. is a premier source for the development, design, and manufacture of automation solutions and instrumentation for the life sciences industry. RoboDesign offers standard as well as custom products for drug discovery, laboratory and hospital automation. In addition, with its broad range of technical expertise, RoboDesign is uniquely positioned to provide a wide array of engineering services, from rapid prototyping to OEM design and manufacturing. From fully automated pharmacy systems to protein crystal imaging and analysis, RoboDesign's enabling technologies are playing a vital role in all phases of the fight against disease.
For further information, please contact Tommy Bui, Director of Business Development of RoboDesign International, Inc., +1-760-438-5282, email@example.com.
AP Archive: http://photoarchive.ap.org/
PRN Photo Desk, firstname.lastname@example.orgRoboDesign International, Inc.